Implementation of HIT-Enhanced Tobacco Treatment for Hospitalized Smokers

Completed · Not applicable

Conditions studied: Tobacco Use Cessation, Smoking Cessation, Smoking, Tobacco Use Disorder

In brief

This study will implement and test the effectiveness and cost-effectiveness of a tobacco cessation intervention (Academic Detailing + Integrated Tobacco Order Set - AD + ITOS) for adults admitted to the hospital. The intervention will begin during the hospital stay and continue after discharge. The intervention will use resources easily available to most acute care hospitals: computerized physician order entry, physician and nurse education, staff meetings for physicians, nurses and allied health professionals, online learning capabilities, faxing to primary care providers (PCPs), and the telephone counseling and support available from a state smokers' quitline (QL). The investigators hypothesize that the subjects in the intervention arm (AD + ITOS) will be more likely to achieve tobacco abstinence at 12 months post hospital stay than subjects in the control arm (Academic Detailing - AD). Tobacco abstinence will be assessed by self report and biochemical verification (exhaled carbon monoxide reading).

Key facts

Study ID

NCT01691105

Run by

Yale University

People needed

1044

Starts

2013-08-01

Expected to finish

2016-09-01

Last updated by the study team

2021-09-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years or older
• admitted to any medical ward, telemetry or cardiac care unit
• identified as a smoker by the nurse or physician in the admitting EMR
• treated by a study physician
• able to give written informed consent

You may not qualify if…

• inability to read or understand English or Spanish
• lacks capacity to give informed consent
• currently receiving formal tobacco dependence treatment
• current suicide or homicide risk
• current psychotic disorder or life-threatening or unstable medical or psychiatric condition within past 6 months
• unable to provide 2 telephone contact numbers
• unwilling to follow up per study protocol, including release of information to assess treatment engagement at 30-days
• live outside of New Haven County
• leaving the hospital against medical advice
• history of clinically significant allergic reaction to nicotine replacement therapies, varenicline or bupropion
• use of an investigational drug within 30 days
• use of tobacco products other than cigarettes
• women of childbearing potential who are pregnant, nursing, or sexually active and not practicing effective contraception (oral injectable, or implantable contraceptives, intrauterine device, or barrier method with spermicide)
• do not have access to a phone with a CT area code (required to use the CT Tobacco Quitline)

Where it is running

• Yale University — New Haven, Connecticut, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.